Denali Therapeutics
DNLI
DNLI
203 hedge funds and large institutions have $3.18B invested in Denali Therapeutics in 2023 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 84 increasing their positions, 55 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
203
Holders Change
+1
Holders Change %
+0.5%
% of All Funds
3.2%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
27
Increased
84
Reduced
55
Closed
25
Calls
$1.23M
Puts
$416K
Net Calls
+$817K
Net Calls Change
+$10.9M
Top Buyers
| 1 |
1
Wellington Management Group
Boston,
Massachusetts
|
$208M |
| 2 |
2
BlackRock
New York
|
$298M |
| 3 |
3
Morgan Stanley
New York
|
$31.8M |
| 4 |
4
Man Group
London,
United Kingdom
|
$14.9M |
| 5 |
PCH
5
Polar Capital Holdings
London,
United Kingdom
|
$29.7M |
Top Sellers
| 1 |
AVM
1
Arch Venture Management
Chicago,
Illinois
|
$20.5M |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$1.66M |
| 3 |
3
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
$438M |
| 4 |
4
Barclays
London,
United Kingdom
|
$4.68M |
| 5 |
5
Norges Bank
Oslo,
Norway
|
$17.1M |
